267 related articles for article (PubMed ID: 2836062)
21. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.
Scarth JA; Patterson MR; Morgan EL; Macdonald A
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33427604
[TBL] [Abstract][Full Text] [Related]
22. Aristocratic human papillomavirus drove cervical cancer: a study of the therapeutic potential of the combination of interferon with zinc.
Gao YH; Yu L; Liu ZS; Li YF
Mol Cell Biochem; 2021 Feb; 476(2):757-765. PubMed ID: 33099745
[TBL] [Abstract][Full Text] [Related]
23. Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7.
Aarthy M; Panwar U; Singh SK
Sci Rep; 2020 May; 10(1):8661. PubMed ID: 32457393
[TBL] [Abstract][Full Text] [Related]
24. HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
Đukić A; Lulić L; Thomas M; Skelin J; Bennett Saidu NE; Grce M; Banks L; Tomaić V
Pathogens; 2020 Feb; 9(2):. PubMed ID: 32085533
[TBL] [Abstract][Full Text] [Related]
25. Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy.
Pal A; Kundu R
Front Microbiol; 2019; 10():3116. PubMed ID: 32038557
[TBL] [Abstract][Full Text] [Related]
26. Translation Stress Regulates Ribosome Synthesis and Cell Proliferation.
Vadivel Gnanasundram S; Fåhraeus R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486342
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.
Zhu D; Shen H; Tan S; Hu Z; Wang L; Yu L; Tian X; Ding W; Ren C; Gao C; Cheng J; Deng M; Liu R; Hu J; Xi L; Wu P; Zhang Z; Ma D; Wang H
Mol Ther; 2018 Oct; 26(10):2443-2455. PubMed ID: 30241742
[TBL] [Abstract][Full Text] [Related]
28. Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
Tornesello ML; Annunziata C; Tornesello AL; Buonaguro L; Buonaguro FM
Cancers (Basel); 2018 Jun; 10(7):. PubMed ID: 29932446
[TBL] [Abstract][Full Text] [Related]
29. Hacking the Cell: Network Intrusion and Exploitation by Adenovirus E1A.
King CR; Zhang A; Tessier TM; Gameiro SF; Mymryk JS
mBio; 2018 May; 9(3):. PubMed ID: 29717008
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis.
Martinez-Jaramillo E; Garza-Morales R; Wechman SL; Montes de Oca-Luna R; Saucedo-Cardenas O; Shirwan H; Yolcu E; McMasters KM; Gomez-Gutierrez JG
Cancer Invest; 2018 Jan; 36(1):19-27. PubMed ID: 29388837
[TBL] [Abstract][Full Text] [Related]
31. Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation.
Biryukov J; Myers JC; McLaughlin-Drubin ME; Griffin HM; Milici J; Doorbar J; Meyers C
Viruses; 2017 Dec; 9(12):. PubMed ID: 29257050
[TBL] [Abstract][Full Text] [Related]
32. Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.
Garza-Morales R; Yaddanapudi K; Perez-Hernandez R; Riedinger E; McMasters KM; Shirwan H; Yolcu E; Montes de Oca-Luna R; Gomez-Gutierrez JG
Cancer Biol Ther; 2018 Mar; 19(3):188-197. PubMed ID: 29252087
[TBL] [Abstract][Full Text] [Related]
33. PI3Kδ activates E2F1 synthesis in response to mRNA translation stress.
Gnanasundram SV; Pyndiah S; Daskalogianni C; Armfield K; Nylander K; Wilson JB; Fåhraeus R
Nat Commun; 2017 Dec; 8(1):2103. PubMed ID: 29235459
[TBL] [Abstract][Full Text] [Related]
34. The human papillomavirus E7 oncoprotein as a regulator of transcription.
Songock WK; Kim SM; Bodily JM
Virus Res; 2017 Mar; 231():56-75. PubMed ID: 27818212
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus Genotyping and p16(INK4a) Expression in Cervical Lesions: A Combined Test to Avoid Cervical Cancer Progression.
Zouheir Y; Fechtali T; Elgnaoui N
J Cancer Prev; 2016 Jun; 21(2):121-5. PubMed ID: 27390742
[TBL] [Abstract][Full Text] [Related]
36. A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53.
Bechill J; Zhong R; Zhang C; Solomaha E; Spiotto MT
PLoS One; 2016; 11(4):e0154125. PubMed ID: 27124407
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection.
Senba M; Mori N
Oncol Rev; 2012 Oct; 6(2):e17. PubMed ID: 25992215
[TBL] [Abstract][Full Text] [Related]
38. Animal models to study the mutational landscape for oral cavity and oropharyngeal cancers.
Spiotto MT; Pytynia M; Liu GF; Ranck MC; Widau R
J Oral Maxillofac Res; 2013 Apr; 4(1):e1. PubMed ID: 24422024
[TBL] [Abstract][Full Text] [Related]
39. Modeling and molecular dynamics of the intrinsically disordered e7 proteins from high- and low-risk types of human papillomavirus.
Nicolau N; Giuliatti S
J Mol Model; 2013 Sep; 19(9):4025-37. PubMed ID: 23864166
[TBL] [Abstract][Full Text] [Related]
40. The papillomavirus E7 proteins.
Roman A; Munger K
Virology; 2013 Oct; 445(1-2):138-68. PubMed ID: 23731972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
